Literature DB >> 15714425

Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis.

Carolina Garcia Vidal1, Serena Rodríguez Fernández, Javier Martínez Lacasa, Miquel Salavert, Rafael Vidal, Monica Rodríguez Carballeira, Javier Garau.   

Abstract

Six of 284 patients treated with infliximab developed active tuberculosis. Four (67%) of these patients had a paradoxical response to antituberculous therapy. Physicians should be aware of the increased risk of a paradoxical response in this population and should consider the use of corticosteroids when a paradoxical reaction is suspected.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15714425     DOI： 10.1086/427941

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  44 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  Infectious complications associated with monoclonal antibodies and related small molecules.

Authors:  Edsel Maurice T Salvana; Robert A Salata
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

4.  Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.

Authors:  Chih-Chin Kao; Vin-Cent Wu; Hsin-Yun Sun; Che-Hsiung Wu
Journal:  Int Urol Nephrol       Date:  2012-05-25       Impact factor: 2.370

Review 5.  Hepatic abscess as a paradoxical response to antituberculous chemotherapy for tubercular lymphadenitis.

Authors:  Manoj Meena; Neeraj Gupta; Jaiprakash Kewlani; Sabarigirivasan Harish Vijayadeepan Kumararesan
Journal:  BMJ Case Rep       Date:  2015-08-20

6.  [Immune reconstitution inflammatory syndrome after cessation of immunosuppressive therapy].

Authors:  B Ehrenstein
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

7.  Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants.

Authors:  María Pérez-Rueda; Michele Hernández-Cabrera; Adela Francés-Urmeneta; Alfonso Angel-Moreno; Elena Pisos-Álamo; Nieves Jaén-Sánchez; Cristina Carranza-Rodríguez; Jose-Luis Pérez-Arellano
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

Review 8.  Immune reconstitution reactions in human immunodeficiency virus-negative patients: report of a case and review of the literature.

Authors:  Tiffany C Scharschmidt; Erin H Amerson; Oren S Rosenberg; Richard A Jacobs; Timothy H McCalmont; Kanade Shinkai
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

9.  Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients.

Authors:  G Geri; A Passeron; B Heym; J-B Arlet; J Pouchot; L Capron; B Ranque
Journal:  Infection       Date:  2012-12-01       Impact factor: 3.553

10.  Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report.

Authors:  Young Kyung Yoon; Jeong Yeon Kim; Jang Wook Sohn; Min Ja Kim; Ja Seol Koo; Jai Hyun Choi; Dae Won Park
Journal:  J Med Case Rep       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.